Preclinical findings may lead to therapies to help smokers
quit without feeling anxious
Preclinical data suggests inactivation of a specific
sub-class of nicotinic receptors may be an effective strategy to help smokers
quit without feeling anxious, according to Virginia Commonwealth University
researchers.
These findings could one day point researchers to the
development of novel therapies to help smokers quit without feeling anxious.